DENTSPLY SIRONA XRAY is well-poised for growth on a robust product portfolio and continued focus on research and development.

Morgan Stanley analyst Erin Wright maintained a Buy rating on DENTSPLY SIRONA (XRAY – Research Report) today and set a price target of ...

In this article, we are going to take a look at where DENTSPLY SIRONA (NASDAQ:XRAY) stands against other worst 3D printing ...

Key Insights DENTSPLY SIRONA's estimated fair value is US$32.27 based on 2 Stage Free Cash Flow to Equity Current ...

On Thursday, DENTSPLY SIRONA Inc (XRAY) stock saw a modest uptick, ending the day at $26.51 which represents a slight increase of $0.78 or 3.03% from the prior close of $25.73. The stock opened at $26 ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

This was the stock's second consecutive day of losses.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $32.0, a high ...

DENTSPLY SIRONA Inc (XRAY) stock saw a decline, ending the day at $26.17 which represents a decrease of $-0.12 or -0.46% from the prior close of $26.29. The stock opened at $26.4 and touched a low of ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on DENTSPLY SIRONA (XRAY – Research Report) ...

In Q2 2024, the Lazard Equity Franchise Portfolio fell in absolute terms and underperformed its benchmark Index. Click here ...

A-dec Inc., STERIS Corporation, Dentsply Sirona Inc., Midmark Corporation, SciCan Ltd., Tuttnauer Ltd., Planmeca Oy, Zimmer Biomet Holdings, Inc., Melag Medizintechnik oHG, Getinge AB, Schaerer ...